# Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study

Study · id `cardio:ct-nct02378883` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02378883](<https://clinicaltrials.gov/study/NCT02378883>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02378883

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.

## Technical summary

Registry record NCT02378883. Allocation not applicable; no masking; primary purpose treatment. Start 2015-05-18 (actual); primary completion 2018-02-20 (actual). Results posted on 2019-04-29.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 112 participants (enrolled count; ClinicalTrials.gov record NCT02378883, source copy `cardio:ctgov-nct02378883-2019-04-29`, retrieved 2026-11-18)
- Started: 2015-05-18 (actual) (ClinicalTrials.gov record NCT02378883, source copy `cardio:ctgov-nct02378883-2019-04-29`, retrieved 2026-11-18)
- Primary completion: 2018-02-20 (actual) (ClinicalTrials.gov record NCT02378883, source copy `cardio:ctgov-nct02378883-2019-04-29`, retrieved 2026-11-18)
- Completion: 2018-02-20 (actual) (ClinicalTrials.gov record NCT02378883, source copy `cardio:ctgov-nct02378883-2019-04-29`, retrieved 2026-11-18)
- Results first posted: 2019-04-29 (ClinicalTrials.gov record NCT02378883, source copy `cardio:ctgov-nct02378883-2019-04-29`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT02378883, source copy `cardio:ctgov-nct02378883-2019-04-29`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02378883-2019-04-29`, retrieved 2026-11-18)

## The registry's words

- Brief title: Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study
- Condition: Arteriovenous Malformations
- Intervention (Device): Apollo™ Onyx™ Delivery Micro Catheter
- Lead sponsor: Medtronic Neurovascular Clinical Affairs
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arteriovenous malformation (AVM) (`cardio:arteriovenous-malformation`)
- Registry lists this organization as the lead sponsor: Medtronic Neurovascular Clinical Affairs (`cardio:org-medtronic-neurovascular-clinical-affairs`)

## Provenance

Content hash: b55e5159be0bb7c78d2c2bdaa54eeae927abc1b429080af6ddfe6d54c616795d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
